US Orphan Diseases Market
US Orphan Diseases Market Research Report By Disease Type (Genetic Disorders, Metabolic Disorders, Neurological Disorders, Immunodeficiency Disorders, Cognitive Disorders), By Treatment Type (Pharmaceuticals, Gene Therapy, Biologics, Enzyme Replacement Therapy, Small Molecule Therapies), By Route of Administration (Oral, Injectable, Intravenous, Topical, Inhalation), By Patient Age Group (Pediatric, Adult, Geriatric) and By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Specialty Pharmacy) - Forecast to 2035
US Orphan Diseases Market Overview
As per MRFR analysis, the US Orphan Diseases Market Size was estimated at 37.17 (USD Billion) in 2023. The US Orphan Diseases Market Industry is expected to grow from 39.53 (USD Billion) in 2024 to 78 (USD Billion..